Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ralph Corey

Showing results (111-120 of 157) with videos related to

Pageof 16
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2006
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremiaMartin E Stryjewski, Lynda A Szczech, Daniel K Benjamin, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 studyMartin E Stryjewski, Vivian H Chu, William D O'Riordan, et al.
Scandinavian Journal of Infectious Diseases|July 11, 2008
Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infectionsTahaniyat Lalani, Vivian H Chu, Chelsea A Grussemeyer, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2018
A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study)Thomas L Holland, William O'Riordan, Alison McManus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2017
Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership GroupSarah B Doernberg, Thomas P Lodise, Joshua T Thaden, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2004
Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged DatabaseVivian H Chu, Christopher H Cabell, Elias Abrutyn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organismsMartin E Stryjewski, Donald R Graham, Samuel E Wilson, et al.
American Heart Journal|November 18, 2005
Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged DatabaseChristopher H Cabell, Elias Abrutyn, Vance G Fowler, et al.
The Journal of Infectious Diseases|October 9, 2007
Expression of antimicrobial peptides in the normal and involved skin of patients with infective cellulitisMartin E Stryjewski, Russell P Hall, Vivian H Chu, et al.
The Journal of Infectious Diseases|August 4, 2007
Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infectionVance G Fowler, Charlotte L Nelson, Lauren M McIntyre, et al.
Pageof 16

Showing results (111-120 of 157) with videos related to

Sort By:
Pageof 16
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2006
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremiaMartin E Stryjewski, Lynda A Szczech, Daniel K Benjamin, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 studyMartin E Stryjewski, Vivian H Chu, William D O'Riordan, et al.
Scandinavian Journal of Infectious Diseases|July 11, 2008
Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infectionsTahaniyat Lalani, Vivian H Chu, Chelsea A Grussemeyer, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2018
A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study)Thomas L Holland, William O'Riordan, Alison McManus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2017
Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership GroupSarah B Doernberg, Thomas P Lodise, Joshua T Thaden, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2004
Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged DatabaseVivian H Chu, Christopher H Cabell, Elias Abrutyn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organismsMartin E Stryjewski, Donald R Graham, Samuel E Wilson, et al.
American Heart Journal|November 18, 2005
Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged DatabaseChristopher H Cabell, Elias Abrutyn, Vance G Fowler, et al.
The Journal of Infectious Diseases|October 9, 2007
Expression of antimicrobial peptides in the normal and involved skin of patients with infective cellulitisMartin E Stryjewski, Russell P Hall, Vivian H Chu, et al.
The Journal of Infectious Diseases|August 4, 2007
Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infectionVance G Fowler, Charlotte L Nelson, Lauren M McIntyre, et al.
Pageof 16